AVEO Pharmaceuticals Inc
AVEO
Market Cap$0
Close$
$18.30
22% upside
Current Fair Value
22% upsideUndervalued by 22% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-38,720,000.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.86 |
| Beta | 0 |
| Outstanding Shares | 34,618,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -5.25 |
|---|---|
| PEG | 7.66 |
| Price to Sales | 7.5 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -0.41 |
| Enterprise Value to EBIT | 1.58 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -1 |
| Debt to Equity | 1.34 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About AVEO Pharmaceuticals Inc
CEO: Michael Bailey